论文部分内容阅读
目的:研究沐舒坦雾化治疗慢性支气管炎急性发作症状的临床效果。方法:择取该院自2014年9月至2015年9月收治的86例慢性支气管炎老年患者,按照患者入院的顺序随机分为观察组和参照组,两组各43例。观察两组患者的治疗有效率和症状改善情况。结果:经过治疗,观察组患者症状恢复情况较佳,急性发作症状较少,治疗有效率高,而参照组的症状恢复情况和治疗有效率较差,两组之间的对比具有统计学意义(P<0.05)。结论:沐舒坦雾化慢性支气管炎的疗效较佳,症状有明显的改善,值得在临床上应用。
Objective: To study the clinical effect of mucosolvan atomizing treatment of acute exacerbation of chronic bronchitis. Methods: Eighty-six elderly patients with chronic bronchitis admitted from September 2014 to September 2015 in our hospital were randomly divided into observation group and reference group according to the order of admission. There were 43 patients in each group. The treatment efficiency and symptom improvement in both groups were observed. Results: After treatment, symptom recovery in observation group was better, symptom of acute attack was less, treatment efficiency was higher, while symptom recovery and treatment efficiency in reference group were poorer, the comparison between the two groups was statistically significant ( P <0.05). Conclusion: Mucosolvan nebulized chronic bronchitis has better curative effect, obvious improvement of symptoms and is worthy of clinical application.